Manar M Elzayat

Publications

• Research Article   
  Comparative study between hypo-fractionated simultaneous integrated boost-intensity modulated radiotherapy combined with Temozolomide versus 3D conformal radiotherapy combined with Temozolomide in treatment of Glioblastoma Multiforme
  Author(s): Manar M Elzayat*, Hanan Shawky Mahmoud, Lamiss Mohamed Abd Aziz and Radwa A Awad
  
  Background: Glioblastoma Multiform (GBM) is the most common primary brain tumor in adults representing the most common diffuse glioma. The aim of this work is to evaluate patients' characteristics of both treatment groups Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) with Temozolomide (TMZ) vs. standard Three-Dimensional Conformal Radiation Therapy (3DCRT) with TMZ, compare the therapeutic index of treatment and Dosimetric differences of 3DCRT plans to that of SIB-IMRT in GBM patients. Methods: This prospective hospital-based study was carried out on 40 patients at clinical oncology department, Tanta University Hospitals, Egypt. Patients aged ≥ 18 years old, both sexes, newly with diagnosed GBM, performance status 0-2, adequate hematological, liver and renal functions. Patients w.. Read More»
  

  Abstract HTML PDF